Health  Vol.5 No.7 D , July 2013
Two cases of venous sinus thrombosis in women taking the oral contraceptive pill, Yaz (dropirenone/ ethinyl estradiol), and review of the literature

Cerebral venous sinus thrombosis (CVT) is a rare cause of stroke and the clinical presentation is variable, thus mimicking other neurologic pathologies. One of the more common acquired risk factors of venous sinus thrombosis is oral contraceptive medications such as Yaz. While the prognosis for CVT is favorable, it is important to identify and treat early to prevent neurologic deficits. We report two cases of young female patients who presented with sinus thrombosis and review the current literature on this topic. CVT accounts for 0.5% of strokes and most commonly presents with headaches and in many cases focal neurologic deficits. Diagnosis is confirmed with neuroimaging including CT angiography or MR angiography. Treatment consists of anticoagulation and in some cases, thrombolytic therapy is beneficial. The overall prognosis of CVT is favorable but, further research is needed to outline optimal treatment options including the duration of anticoagulation therapy and the role of thrombolytic therapy to prevent serious neurologic deficits.

Cite this paper: Riordan, M. and Deshaies, E. (2013) Two cases of venous sinus thrombosis in women taking the oral contraceptive pill, Yaz (dropirenone/ ethinyl estradiol), and review of the literature. Health, 5, 92-99. doi: 10.4236/health.2013.57A4013.

[1]   Ferro, J.M., Canhao, P., Stam, J., Bousser, M.-G. and Barinagarrementeria, F. (2004) Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke: A Journal of Cerebral Circulation, 35, 664-670. doi:10.1161/01.STR.0000117571.76197.26

[2]   Khealani, B.A., Wasay, M., Saadah, M., Sultana, E., Mustafa, S., Khan, F.S. and Kamal, A.K. (2008) Cerebral venous thrombosis: A descriptive multicenter study of patients in Pakistan and Middle East. Stroke: A Journal of Cerebral Circulation, 39, 2707-2711. doi:10.1161/STROKEAHA.107.512814

[3]   Christo, P.P., Carvalho, G.M. de and Gomes Neto, A.P. (2010) Cerebral venous thrombosis: Study of fifteen cases and review of literature. Revista da Associacao Médica Brasileira (1992), 56, 288-292. doi:10.1590/S0104-42302010000300011

[4]   Ehtisham, A. and Stern, B.J. (2006) Cerebral venous thrombosis: A review. The neurologist, 12, 32-38. doi:10.1097/01.nrl.0000178755.90391.b6

[5]   Filippidis, A., Kapsalaki, E., Patramani, G. and Fountas, K.N. (2009) Cerebral venous sinus thrombosis: Review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurgical Focus, 27, E3. doi:10.3171/2009.8.FOCUS09167

[6]   Bentley, J.N., Figueroa, R.E. and Vender, J.R. (2009) From presentation to follow-up: Diagnosis and treatment of cerebral venous thrombosis. Neurosurgical Focus, 27, E4. doi:10.3171/2009.8.FOCUS09166

[7]   McBane, R.D., Tafur, A. and Wysokinski, W.E. (2010) Acquired and congenital risk factors associated with cerebral venous sinus thrombosis. Thrombosis Research, 126, 81-87. doi:10.1016/j.thromres.2010.04.015

[8]   Sehovic, N. and Smith, K.P. (2010) Risk of venous thromboembolism with drospirenone in combined oral contraceptive products. The Annals of Pharmacotherapy, 44, 898-903. doi:10.1345/aph.1M649

[9]   Bachmann, G. and Kopacz, S. (2009) Drospirenone/ethinyl estradiol 3 mg/20 mug (24/4 day regimen): Hormonal contraceptive choices—Use of a fourth-generation progestin. Patient Preference and Adherence, 3, 259-264. doi:10.2147/PPA.S3901

[10]   Kaunitz, A.M., Burkman, R.T., Fisher, A.C. and Laguardia, K.D. (2009) Cycle control with a 21-day compared with a 24-day oral contraceptive pill: A randomized controlled trial. Obstetrics and Gynecology, 114, 1205-1212. doi:10.1097/AOG.0b013e3181beab47

[11]   Rapkin, A.J., Sorger, S.N. and Winer, S.A. (2008) Drospirenone/ethinyl estradiol. Drugs of Today (Barcelona, Spain: 1998), 44, 133-145. doi:10.1358/dot.2008.44.2.1191057

[12]   López, M., Vayá, A., Martínez Triguero, M.L., Contreras, M.T., Todolí, J., Ricart, A. and Laiz, B. (2009) Yasmin and venous thromboembolism: New case reports. Clinical Hemorheology and Microcirculation, 42, 65-69.

[13]   Sahraian, M.A., Akbari, H., Khajavi, M.R., Najafi, A. and Khashayar, P. (2010) The risk factors and the treatment course of cerebral venous thrombosis: An experience of 41 cases. Acta Neurologica Belgica, 110, 230-233.

[14]   Bousser, M.G., Chiras, J., Bories, J. and Castaigne, P. (1985) Cerebral venous thrombosis—A review of 38 cases. Stroke: A Journal of Cerebral Circulation, 16, 199-213. doi:10.1161/01.STR.16.2.199

[15]   Fischer, C., Goldstein, J. and Edlow, J. (2010) Cerebral venous sinus thrombosis in the emergency department: Retrospective analysis of 17 cases and review of the literature. The Journal of Emergency Medicine, 38, 140-147. doi:10.1016/j.jemermed.2009.08.061

[16]   Appenzeller, S., Zeller, C.B., Annichino-Bizzachi, J.M., Costallat, L.T.L., Deus-Silva, L., Voetsch, B. and Cendes, F. (2005) Cerebral venous thrombosis: Influence of risk factors and imaging findings on prognosis. Clinical Neurology and Neurosurgery, 107, 371-378. doi:10.1016/j.clineuro.2004.10.004

[17]   Khandelwal, N., Agarwal, A., Kochhar, R., Bapuraj, J.R., Singh, P., Prabhakar, S. and Suri, S. (2006) Comparison of CT venography with MR venography in cerebral sinovenous thrombosis. AJR. American Journal of Roentgenology, 187, 1637-1643. doi:10.2214/AJR.05.1249

[18]   Shahsavarzadeh, T., Javanmard, S.H. and Saadatnia, M. (2011) Impact of factor VIII and von Willebrand factor plasma levels on cerebral venous and sinus thrombosis: Are they independent risk factors? European Neurology, 66, 243-246. doi:10.1159/000331048

[19]   Soleau, S.W., Schmidt, R., Stevens, S., Osborn, A. and MacDonald, J.D. (2003) Extensive experience with dural sinus thrombosis. Neurosurgery, 52, 534-544. doi:10.1227/01.NEU.0000047815.21786.C1

[20]   Coutinho, J.M., Ferro, J.M., Canhao, P., Barinagarrementeria, F., Bousser, M.-G. and Stam, J. (2010) Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke: A Journal of Cerebral Circulation, 41, 2575-2580. doi:10.1161/STROKEAHA.110.588822

[21]   Galarza, M. and Gazzeri, R. (2009) Cerebral venous sinus thrombosis associated with oral contraceptives: The case for neurosurgery. Neurosurgical Focus, 27, E5. doi:10.3171/2009.8.FOCUS09158

[22]   Bousser, M.G. (2000) Cerebral venous thrombosis: Diagnosis and management. Journal of Neurology, 247, 252-258. doi:10.1007/s004150050579

[23]   Saposnik, G., Barinagarrementeria, F., Brown Jr., R.D., Bushnell, C.D., Cucchiara, B., Cushman, M. and Tsai, F.Y. (2011) Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke: A Journal of Cerebral Circulation, 42, 1158-1192. doi:10.1161/STR.0b013e31820a8364

[24]   Dunne, C., Malyuk, D. and Firoz, T. (2010) Cerebral venous sinus thrombosis in a woman using the etonogestrelethinyl estradiol vaginal contraceptive ring: A case report. Journal of Obstetrics and Gynaecology Canada: JOGC = Journal D’obstétrique et Gynécologie du Canada: JOGC, 32, 270-273.

[25]   Kolacki, C. and Rocco, V. (2012) The combined vaginal contraceptive ring, nuvaring, and cerebral venous sinus thrombosis: A case report and review of the literature. The Journal of Emergency Medicine, 42, 413-416. doi:10.1016/j.jemermed.2011.06.011

[26]   Ben Salem-Berrabah, O., Fekih-Mrissa, N., N’siri, B., Ben Hamida, A., Benammar-Elgaaied, A., Gritli, N. and Mrissa, R. (2012) Thrombophilic polymorphisms-factor V Leiden G1691A, prothrombin G20210A and MTHFR C677Tin Tunisian patients with cerebral venous thrombosis. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia, 19, 1326-1327. doi:10.1016/j.jocn.2011.11.029

[27]   Nagai, M., Terao, S., Yilmaz, G., Yilmaz, C.E., Esmon, C. T., Watanabe, E. and Granger, D.N. (2010) Roles of inflammation and the activated protein C pathway in the brain edema associated with cerebral venous sinus thrombosis. Stroke: A Journal of Cerebral Circulation, 41, 147-152. doi:10.1161/STROKEAHA.109.562983

[28]   Stam, J. (2005) Thrombosis of the cerebral veins and sinuses. The New England Journal of Medicine, 352, 1791-1798. doi:10.1056/NEJMra042354

[29]   Leach, J.L., Fortuna, R.B., Jones, B.V. and Gaskill-Shipley, M.F. (2006) Imaging of cerebral venous thrombosis: Current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics: A Review Publication of the Radiological Society of North America, Inc., 26, S19-S41. doi:10.1148/rg.26si055174

[30]   Crassard, I., Soria, C., Tzourio, C., Woimant, F., Drouet, L., Ducros, A. and Bousser, M.-G. (2005) A negative Ddimer assay does not rule out cerebral venous thrombosis: A series of seventy-three patients. Stroke: A Journal of Cerebral Circulation, 36, 1716-1719. doi:10.1161/01.STR.0000173401.76085.98

[31]   Martinelli, I., Bucciarelli, P., Passamonti, S.M., Battaglioli, T., Previtali, E. and Mannucci, P.M. (2010) Longterm evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation, 121, 2740-2746. doi:10.1161/CIRCULATIONAHA.109.927046

[32]   Kosinski, C.M., Mull, M., Schwarz, M., Koch, B., Biniek, R., Schlafer, J. and Schiefer, J. (2004) Do normal D-dimer levels reliably exclude cerebral sinus thrombosis? Stroke: A Journal of Cerebral Circulation, 35, 2820-2825. doi:10.1161/01.STR.0000147045.71923.18

[33]   Einhaupl, K.M., Villringer, A., Meister, W., Mehraein, S., Garner, C., Pellkofer, M. and Schmiedek, P. (1991) Heparin treatment in sinus venous thrombosis. Lancet, 338, 597-600. doi:10.1016/0140-6736(91)90607-Q

[34]   Coutinho, J.M. and Stam, J. (2010) How to treat cerebral venous and sinus thrombosis. Journal of Thrombosis and Haemostasis: JTH, 8, 877-883. doi:10.1111/j.1538-7836.2010.03799.x

[35]   De Bruijn, S.F. and Stam, J. (1999) Randomized, placebo-controlled trial of anticoagulant treatment with low molecular-weight heparin for cerebral sinus thrombosis. Stroke: A Journal of Cerebral Circulation, 30, 484-488. doi:10.1161/01.STR.30.3.484

[36]   Ferro, J.M. and Canhao, P. (2008) Acute treatment of cerebral venous and dural sinus thrombosis. Current treatment options in neurology, 10, 126-137. doi:10.1007/s11940-008-0014-0

[37]   Coutinho, J., de Bruijn, S.F., Deveber, G. and Stam, J. (2011) Anticoagulation for cerebral venous sinus thrombosis. Cochrane Database of Systematic Reviews (Online), 8, CD002005. doi:10.1002/14651858.CD002005.pub2

[38]   Ferro, J.M., Canhao, P., Bousser, M.-G., Stam, J. and Barinagarrementeria, F. (2008) Early seizures in cerebral vein and dural sinus thrombosis: Risk factors and role of antiepileptics. Stroke: A Journal of Cerebral Circulation, 39, 1152-1158. doi:10.1161/STROKEAHA.107.487363

[39]   Wasay, M., Bakshi, R., Kojan, S., Bobustuc, G., Dubey, N. and Unwin, D.H. (2001) Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke: A Journal of Cerebral Circulation, 32, 2310-2317. doi:10.1161/hs1001.096192

[40]   Stam, J., Majoie, C.B.L.M., van Delden, O.M., van Lienden, K.P. and Reekers, J.A. (2008) Endovascular thrombectomy and thrombolysis for severe cerebral sinus thrombosis: A prospective study. Stroke: A Journal of Cerebral Circulation, 39, 1487-1490. doi:10.1161/STROKEAHA.107.502658

[41]   Canhao, P., Falcao, F. and Ferro, J.M. (2003) Thrombolytics for cerebral sinus thrombosis: A systematic review. Cerebrovascular Diseases (Basel, Switzerland), 15, 159-166. doi:10.1159/000068833

[42]   Kim, S.Y. and Suh, J.H. (1997) Direct endovascular thrombolytic therapy for dural sinus thrombosis: Infusion of alteplase. AJNR. American Journal of Neuroradiology, 18, 639-645.

[43]   Horowitz, M., Purdy, P., Unwin, H., Carstens 3rd, G., Greenlee, R., Hise, J. and Samson, D. (1995) Treatment of dural sinus thrombosis using selective catheterization and urokinase. Annals of Neurology, 38, 58-67. doi:10.1002/ana.410380112

[44]   Medel, R., Monteith, S.J., Crowley, R.W. and Dumont, A.S. (2009) A review of therapeutic strategies for the management of cerebral venous sinus thrombosis. Neurosurgical Focus, 27, E6. doi:10.3171/2009.8.FOCUS09154

[45]   Agner, C., Deshaies, E.M., Bernardini, G.L., Popp, A.J. and Boulos, A.S. (2005) Coronary angiojet catheterizetion for the management of dural venous sinus thrombosis. Technical note. Journal of neurosurgery, 103, 368-371. doi:10.3171/jns.2005.103.2.0368

[46]   Curtin, K.R., Shaibani, A., Resnick, S.A., Russell, E.J. and Simuni, T. (2004) Rheolytic catheter thrombectomy, balloon angioplasty, and direct recombinant tissue plasminogen activator thrombolysis of dural sinus thrombosis with preexisting hemorrhagic infarctions. AJNR. American Journal of Neuroradiology, 25, 1807-1811.

[47]   Nimjee, S.M., Powers, C.J., Kolls, B.J., Smith, T., Britz, G.W. and Zomorodi, A.R. (2011) Endovascular treatment of venous sinus thrombosis: A case report and review of the literature. Journal of Neurointerventional Surgery, 3, 30-33. doi:10.1136/jnis.2010.002469

[48]   Chow, K., Gobin, Y.P., Saver, J., Kidwell, C., Dong, P. and Vinuela, F. (2000) Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intraarterial thrombolysis. Stroke: A Journal of Cerebral Circulation, 31, 1420-1425. doi:10.1161/01.STR.31.6.1420

[49]   Chaloupka, J.C., Mangla, S. and Huddle, D.C. (1999) Use of mechanical thrombolysis via microballoon percutaneous transluminal angioplasty for the treatment of acute dural sinus thrombosis: Case presentation and technical report. Neurosurgery, 45, 650-656. doi:10.1097/00006123-199909000-00045

[50]   Rahman, M., Velat, G.J., Hoh, B.L. and Mocco, J. (2009) Direct thrombolysis for cerebral venous sinus thrombosis. Neurosurgical Focus, 27, E7. doi:10.3171/2009.7.FOCUS09146

[51]   Chahlavi, A., Steinmetz, M.P., Masaryk, T.J. and Rasmussen, P.A. (2004) A transcranial approach for direct mechanical thrombectomy of dural sinus thrombosis. Report of two cases. Journal of Neurosurgery, 101, 347-351. doi:10.3171/jns.2004.101.2.0347

[52]   Dashti, S.R., Hu, Y.C., Yao, T., Fiorella, D., Mitha, A.P., Albuquerque, F.C. and McDougall, C.G. (2011) Mechanical thrombectomy as first-line treatment for venous sinus thrombosis: Technical considerations and preliminary results using the AngioJet device. Journal of Neurointerventional Surgery, 5, 49-53. doi:10.1136/neurintsurg-2011-010112

[53]   Ferro, J.M., Lopes, M.G., Rosas, M.J., Ferro, M.A. and Fontes, J. (2002) Long-term prognosis of cerebral vein and dural sinus thrombosis. Cerebrovascular Diseases (Basel, Switzerland), 13, 272-278. doi:10.1159/000057855

[54]   Gosk-Bierska, I., Wysokinski, W., Brown Jr., R.D., Karnicki, K., Grill, D., Wiste, H. and McBane 2nd, R.D. (2006) Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology, 67, 814-819. doi:10.1212/01.wnl.0000233887.17638.d0

[55]   Miranda, B., Ferro, J.M., Canhao, P., Stam, J., Bousser, M.G., Barinagarrementeria, F. and Scoditti, U. (2010) Venous thromboembolic events after cerebral vein thrombosis. Stroke: A Journal of Cerebral Circulation, 41, 1901-1906. doi:10.1161/STROKEAHA.110.581223.